跳至主要内容
临床试验/ISRCTN14567609
ISRCTN14567609已完成3 期

Improving outcomes in fistula intervention: A prospective, patient blinded, phase III, randomised controlled trial of drug eluting balloons in the angioplasty of native haemodialysis access arterio-venous fistula outflow stenosis

niversity Hospital Birmingham NHS Foundation Trust0 个研究点目标入组 92 人开始时间: 2016年1月20日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
92

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Arteriovenous (AV) fistulas with stenosis requiring percutaneous angioplasty identified on routine diagnostic imaging or causing clinical concern on dialysis
  • 2. Fistula has been in use for at least 1 month and is more than 6 weeks old
  • 3. Brachiocephalic AV fistula
  • 4. Brachiobasilic AV fistula
  • 5. Radiocephalic AV fistula (both proximal and distal)
  • 6. Aged 18 years or over
  • 7. Index lesion is less then the length of the DEB, and the reference vessel diameter is appropriate for treatment with the size range of DEB (4mm ­ 8mm diameter)
  • 8. Capacity to give valid informed consent

排除标准

  • 1. Allergy to iodinated Intravenous contrast
  • 2. Allergy to Paclitaxel
  • 3. Prosthetic grafts
  • 4. Long or tandem lesions that cannot be treated with a single DEB
  • 5. Thrombosed Arterio­Venous fistulas
  • 6. Women who are breastfeeding, pregnant or intending to become pregnant
  • 7. Participants of child­bearing age who are unwilling to use a reliable form of contraception for the duration of the study

研究者

发起方
niversity Hospital Birmingham NHS Foundation Trust

相似试验